Patent 10358427 was granted and assigned to GlaxoSmithKline on July, 2019 by the United States Patent and Trademark Office.
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.